4 Clinical Trials for Various Conditions
A randomized, evaluator-blinded study to assess skin irritation and skin sensitization of HP-1050 transdermal system (HP-1050) in comparison to XULANE patch in healthy female volunteers.
The study will assess skin irritation as well as sensitization for d-ATS patch in healthy subjects.
The purpose of this clinical trial is to evaluate the dermal safety of Bemotrizinol (6%).
A Cumulative Patch Test with a Challenge Phase is a test devised to ascertain if a chemical agent or agents have the potential to cause contact irritation or contact allergy in the skin. Allergy is only elicited in immunologically competent individuals who have become sensitized through exposure to the chemical agent at a sufficient concentration and for a sufficient duration of time.